Correlation Between Invesco NASDAQ and Innovator IBD

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Invesco NASDAQ and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invesco NASDAQ and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invesco NASDAQ 100 and Innovator IBD 50, you can compare the effects of market volatilities on Invesco NASDAQ and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invesco NASDAQ with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invesco NASDAQ and Innovator IBD.

Diversification Opportunities for Invesco NASDAQ and Innovator IBD

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Invesco and Innovator is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Invesco NASDAQ 100 and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and Invesco NASDAQ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invesco NASDAQ 100 are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of Invesco NASDAQ i.e., Invesco NASDAQ and Innovator IBD go up and down completely randomly.

Pair Corralation between Invesco NASDAQ and Innovator IBD

Given the investment horizon of 90 days Invesco NASDAQ is expected to generate 1.2 times less return on investment than Innovator IBD. But when comparing it to its historical volatility, Invesco NASDAQ 100 is 1.77 times less risky than Innovator IBD. It trades about 0.11 of its potential returns per unit of risk. Innovator IBD 50 is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  2,695  in Innovator IBD 50 on September 23, 2024 and sell it today you would earn a total of  222.00  from holding Innovator IBD 50 or generate 8.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Invesco NASDAQ 100  vs.  Innovator IBD 50

 Performance 
       Timeline  
Invesco NASDAQ 100 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco NASDAQ 100 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very sluggish basic indicators, Invesco NASDAQ may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Innovator IBD 50 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Innovator IBD may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Invesco NASDAQ and Innovator IBD Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Invesco NASDAQ and Innovator IBD

The main advantage of trading using opposite Invesco NASDAQ and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invesco NASDAQ position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.
The idea behind Invesco NASDAQ 100 and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity